{"id":"https://openalex.org/W4367052583","doi":"https://doi.org/10.4155/fmc-2023-0025","title":"Synthesis and In Vitro Study of pyrimidine\u2013phthalimide Hybrids As VEGFR2 Inhibitors With Antiproliferative Activity","display_name":"Synthesis and In Vitro Study of pyrimidine\u2013phthalimide Hybrids As VEGFR2 Inhibitors With Antiproliferative Activity","publication_year":2023,"publication_date":"2023-04-01","ids":{"openalex":"https://openalex.org/W4367052583","doi":"https://doi.org/10.4155/fmc-2023-0025","pmid":"https://pubmed.ncbi.nlm.nih.gov/37125606"},"language":"en","primary_location":{"id":"doi:10.4155/fmc-2023-0025","doi":"https://doi.org/10.4155/fmc-2023-0025","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc-2023-0025","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053244206","display_name":"Wael Shehta","orcid":"https://orcid.org/0000-0002-6522-7279","observed_orcids":["https://orcid.org/0000-0002-6522-7279"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Wael Shehta","raw_affiliation_strings":["Department of Chemistry Faculty of Science Zagazig University\rZagazig\r44519\rEgypt"],"raw_orcid":"https://orcid.org/0000-0002-6522-7279","affiliations":[{"raw_affiliation_string":"Department of Chemistry Faculty of Science Zagazig University\rZagazig\r44519\rEgypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072025974","display_name":"Fatimah Agili","orcid":"https://orcid.org/0000-0001-9880-5322","observed_orcids":["https://orcid.org/0000-0001-9880-5322"]},"institutions":[{"id":"https://openalex.org/I91450128","display_name":"Jazan University","ror":"https://ror.org/02bjnq803","country_code":"SA","type":"education","lineage":["https://openalex.org/I91450128"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Fatimah Agili","raw_affiliation_strings":["Department of Chemistry, Faculty of Science (Girls Section), Jazan University, Jazan, 45142, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Faculty of Science (Girls Section), Jazan University, Jazan, 45142, Saudi Arabia","institution_ids":["https://openalex.org/I91450128"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062539059","display_name":"Basant Farag","orcid":"https://orcid.org/0000-0002-5513-9945","observed_orcids":["https://orcid.org/0000-0002-5513-9945"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Basant Farag","raw_affiliation_strings":["Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049526562","display_name":"Shaker Youssif","orcid":"https://orcid.org/0000-0003-2623-0261","observed_orcids":["https://orcid.org/0000-0003-2623-0261"]},"institutions":[{"id":"https://openalex.org/I192398990","display_name":"Zagazig University","ror":"https://ror.org/053g6we49","country_code":"EG","type":"education","lineage":["https://openalex.org/I192398990"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Shaker Youssif","raw_affiliation_strings":["Department of Chemistry Faculty of Science Zagazig University\rZagazig\r44519\rEgypt"],"raw_orcid":"https://orcid.org/0000-0003-2623-0261","affiliations":[{"raw_affiliation_string":"Department of Chemistry Faculty of Science Zagazig University\rZagazig\r44519\rEgypt","institution_ids":["https://openalex.org/I192398990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020490254","display_name":"Samar J. Almehmadi","orcid":"https://orcid.org/0000-0001-5848-9679","observed_orcids":["https://orcid.org/0000-0001-5848-9679"]},"institutions":[{"id":"https://openalex.org/I199693650","display_name":"Umm al-Qura University","ror":"https://ror.org/01xjqrm90","country_code":"SA","type":"education","lineage":["https://openalex.org/I199693650"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Samar J Almehmadi","raw_affiliation_strings":["Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Mecca, 24451, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Mecca, 24451, Saudi Arabia","institution_ids":["https://openalex.org/I199693650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023024815","display_name":"Sherin M. Elfeky","orcid":"https://orcid.org/0000-0002-5774-8007","observed_orcids":["https://orcid.org/0000-0002-5774-8007"]},"institutions":[{"id":"https://openalex.org/I159247623","display_name":"Mansoura University","ror":"https://ror.org/01k8vtd75","country_code":"EG","type":"education","lineage":["https://openalex.org/I159247623"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Sherin M Elfeky","raw_affiliation_strings":["Pharmaceutical Organic Chemistry Faculty of Pharmacy Mansoura University\rMansoura\r355516\rEgypt"],"raw_orcid":"https://orcid.org/0000-0002-5774-8007","affiliations":[{"raw_affiliation_string":"Pharmaceutical Organic Chemistry Faculty of Pharmacy Mansoura University\rMansoura\r355516\rEgypt","institution_ids":["https://openalex.org/I159247623"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010124559","display_name":"Samar A. El-Kalyoubi","orcid":"https://orcid.org/0000-0002-4648-5184","observed_orcids":["https://orcid.org/0000-0002-4648-5184"]},"institutions":[{"id":"https://openalex.org/I88017793","display_name":"Port Said University","ror":"https://ror.org/01vx5yq44","country_code":"EG","type":"education","lineage":["https://openalex.org/I88017793"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Samar El-Kalyoubi","raw_affiliation_strings":["Pharmaceutical Organic Chemistry Faculty of Pharmacy Port Said University\rPort Said\r42511\rEgypt"],"raw_orcid":"https://orcid.org/0000-0002-4648-5184","affiliations":[{"raw_affiliation_string":"Pharmaceutical Organic Chemistry Faculty of Pharmacy Port Said University\rPort Said\r42511\rEgypt","institution_ids":["https://openalex.org/I88017793"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9731,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.66736156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"15","issue":"8","first_page":"661","last_page":"677"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thalidomide-analogs","display_name":"thalidomide analogues","score":0.8370000123977661},{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/nucleophilic-substitution","display_name":"nucleophilic substitution","score":0.6660000085830688},{"id":"https://openalex.org/keywords/aliphatic-amines","display_name":"aliphatic amines","score":0.8489999771118164},{"id":"https://openalex.org/keywords/s-phase-arrest","display_name":"S phase arrest","score":0.7239999771118164},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/selective-cytotoxicity","display_name":"selective cytotoxicity","score":0.7609999775886536},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.5730000138282776},{"id":"https://openalex.org/keywords/anticancer-drug-design","display_name":"anticancer drug design","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C2778522978","wikidata":"https://www.wikidata.org/wiki/Q412784","display_name":"Phthalimide","level":2,"score":0.8977608680725098},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.7557957768440247},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5610116720199585},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5438480973243713},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5220027565956116},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5193977952003479},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4169452488422394},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28911271691322327}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061986","descriptor_name":"MCF-7 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4155/fmc-2023-0025","doi":"https://doi.org/10.4155/fmc-2023-0025","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc-2023-0025","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:37125606","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37125606","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8999999761581421,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1725090888","https://openalex.org/W1995853598","https://openalex.org/W1998360317","https://openalex.org/W2014329705","https://openalex.org/W2018206586","https://openalex.org/W2019061836","https://openalex.org/W2023325881","https://openalex.org/W2028563664","https://openalex.org/W2033495141","https://openalex.org/W2035387891","https://openalex.org/W2048986076","https://openalex.org/W2059904332","https://openalex.org/W2063544208","https://openalex.org/W2077804275","https://openalex.org/W2079398727","https://openalex.org/W2085663480","https://openalex.org/W2086932621","https://openalex.org/W2089411683","https://openalex.org/W2103293485","https://openalex.org/W2123334268","https://openalex.org/W2124662474","https://openalex.org/W2127319994","https://openalex.org/W2132242107","https://openalex.org/W2194596377","https://openalex.org/W2395523735","https://openalex.org/W2396930286","https://openalex.org/W2593436234","https://openalex.org/W2790147358","https://openalex.org/W2901992810","https://openalex.org/W2939948690","https://openalex.org/W2955199841","https://openalex.org/W2981810096","https://openalex.org/W3033827703","https://openalex.org/W3039947924","https://openalex.org/W3186877437","https://openalex.org/W4200344701","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W7212457411","https://openalex.org/W3180992221","https://openalex.org/W4313583161","https://openalex.org/W4284882937","https://openalex.org/W4317871089","https://openalex.org/W4309513585","https://openalex.org/W2263549024","https://openalex.org/W1521480162","https://openalex.org/W4400451262","https://openalex.org/W7204862723"],"abstract_inverted_index":{"Aim:":[0],"Thalidomide,":[1],"a":[2,20,146],"once":[3],"notorious":[4],"sedative,":[5],"is":[6],"now":[7],"clinically":[8],"used":[9],"as":[10,19],"an":[11],"antitumor":[12],"agent.":[13],"We":[14],"aimed":[15],"to":[16,149],"use":[17],"it":[18],"lead":[21],"compound":[22],"for":[23,91],"designing":[24],"pyrimidine\u2013phthalimide":[25,44],"hybrids.":[26],"Materials":[27],"&":[28,51],"methods:":[29],"Nucleophilic":[30],"substitution":[31],"reaction":[32],"of":[33,105,130],"thalidomide":[34],"analog":[35],"4":[36],"with":[37,88,141],"primary":[38],"and/or":[39],"secondary":[40],"aliphatic":[41],"amines":[42],"afforded":[43],"hybrids":[45],"5a\u2013g,":[46],"6":[47],"and":[48,81,109,143],"7a\u2013d.":[49],"Results":[50],"conclusion:":[52],"Compound":[53],"7c":[54,98,117,127],"showed":[55],"high":[56],"antiproliferative":[57],"activity":[58],"against":[59],"four":[60],"cell":[61,107],"lines:":[62],"HepG-2":[63],"(IC50:":[64,70,76,83,93,122],"7.86":[65],"\u00b1":[66,72,78,85,95,124],"0.5":[67,86],"\u03bcM),":[68,74,87],"MCF-7":[69,100],"2.77":[71],"0.1":[73],"HCT-116":[75],"5.73":[77],"0.4":[79],"\u03bcM)":[80],"PC-3":[82],"8.32":[84],"selective":[89],"cytotoxicity":[90],"WI-38":[92],"43.2":[94],"2.56":[96],"\u03bcM).":[97,126],"arrested":[99],"cells":[101,114],"at":[102,132],"S":[103],"phase":[104],"the":[106,111,133],"cycle":[108],"increased":[110],"total":[112],"apoptotic":[113],"by":[115],"50-fold.":[116],"inhibited":[118],"VEGFR2":[119,134],"in":[120,145],"vitro":[121],"0.130":[123],"0.02":[125],"was":[128],"capable":[129],"binding":[131,135],"site,":[136],"forming":[137],"hydrogen":[138],"bond":[139],"interactions":[140],"Asp1046":[142],"Glu885":[144],"similar":[147],"way":[148],"sorafenib.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-27T00:00:00"}